Thomas Stephan

Stock Analyst at Stifel

(0)
# 3824
Out of 5,240 analysts
37
Total ratings
40.00%
Success rate
-1.39%
Average return
7 Stocks
Name Action Price Target Current % Upside Ratings Updated
RxSight
Maintains: Hold
40 35
30.53 14.64% 8 Jan 13, 2025
Glaukos
Maintains: Strong Buy
153 175
148.56 17.8% 8 Dec 31, 2024
Bausch & Lomb
Maintains: Hold
16 19
17.3 9.83% 2 Sep 23, 2024
Staar Surgical
Maintains: Buy
50 44
22.47 95.82% 8 Aug 26, 2024
Iridex
Maintains: Hold
2 2
1.64 21.95% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
95 100
82.84 20.71% 4 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 7
3.19 119.44% 5 Mar 8, 2024